Efficacy of the antiinfluenza A vaccination during epidemics due to A/VIC/3/75 and A/Texas/1/77 viruses.
D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000032:analysis; D002648:Child; D004196:Disease Outbreaks; D005260:Female; D005602:France; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D007251:Influenza, Human / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D009975:Orthomyxoviridae / Q000276:immunology / Q000302:isolation & purification; D014611:Vaccination
D000914:Antibodies, Viral; D007252:Influenza Vaccines